United BioSource Corporation, Bethesda, Maryland 20814, USA.
Surg Infect (Larchmt). 2011 Aug;12(4):307-16. doi: 10.1089/sur.2010.062.
Surgical site infection (SSI) is an important cause of morbidity and occasionally death after coronary artery bypass graft (CABG) surgery. These infections also are associated with higher costs and poorer surgical outcomes. We used a retrospective observational database to examine and quantify the effects of the topical skin adhesive 2-octyl cyanoacrylate, used as the final layer of site closure in patients undergoing CABG surgery, on the incidence of post-operative SSI.
All patients in the Premier Perspective™ Comparative Database of inpatient hospitalizations who underwent CABG surgery in 2005 and 2006 were identified. Qualifying patients were classified into four groups according to the method of surgical site closure on the basis of detailed hospital billing charges: Sutures only; sutures and 2-octyl cyanoacrylate; sutures and staples; and sutures, 2-octyl cyanoacrylate, and staples. Site infections were identified by a combination of International Classification of Diseases (ICD-9-CM) diagnosis codes, patterns of post-operative use of antibiotics, and All Patient Refined Diagnostic Related Group (APR-DRG) and Diagnostic Related Group (DRG) codes indicating post-operative infections at hospital re-admission.
A total of 59,006 patients qualified for the study: 38,799 who had sutures only; 10,262 having sutures and 2-octyl cyanoacrylate; 8,180 having sutures and staples; and 1,765 having sutures, 2-octyl cyanoacrylate, and staples. The lowest unadjusted rate of post-CABG SSI was found in the sutures and 2-octyl cyanoacrylate group (4.3%; 95% confidence interval [CI] 3.9-4.7), followed by sutures only (5.3%; 95% CI 5.1-5.5); sutures and staples (6.2%; 95% CI 5.7-6.8); and sutures, staples, and 2-octyl cyanoacrylate (7.1%; 95% CI 6.0%-8.4%). A logistic regression model that controlled for selected baseline patient, hospital, and surgical characteristics showed significantly lower rates of post-CABG SSI (odds ratio 0.76; 95% CI 0.68-0.85) in patients closed with sutures and 2-octyl cyanoacrylate relative to patients who had only sutures.
The observed rates of post-CABG SSI were consistent with the rates observed in the literature. The SSI rate for patients who had sutures and 2-octyl cyanoacrylate used as the final layer of site closure was significantly lower than the rates for patients having other types of closure.
外科部位感染(SSI)是冠状动脉旁路移植术(CABG)后发病率和偶尔导致死亡的一个重要原因。这些感染也与更高的成本和更差的手术结果有关。我们使用回顾性观察数据库来检查和量化 2-辛基氰基丙烯酸酯局部皮肤粘合剂的使用,即作为 CABG 手术患者手术部位最后一层封闭的方法,对术后 SSI 发生率的影响。
从 Premier Perspective™住院患者住院比较数据库中确定了 2005 年和 2006 年接受 CABG 手术的所有患者。根据详细的住院费用,根据手术部位闭合方法将合格患者分为四组:仅缝线;缝线和 2-辛基氰基丙烯酸酯;缝线和订书钉;缝线、2-辛基氰基丙烯酸酯和订书钉。通过国际疾病分类(ICD-9-CM)诊断代码、术后抗生素使用模式以及表示术后感染的所有患者精炼诊断相关组(APR-DRG)和诊断相关组(DRG)代码的组合来确定部位感染。
共有 59006 名患者符合研究条件:仅缝线 38799 例;缝线加 2-辛基氰基丙烯酸酯 10262 例;缝线加订书钉 8180 例;缝线、2-辛基氰基丙烯酸酯和订书钉 1765 例。CABG 后 SSI 发生率最低的是缝线加 2-辛基氰基丙烯酸酯组(4.3%;95%置信区间[CI]3.9-4.7%),其次是仅缝线组(5.3%;95%CI 5.1-5.5%);缝线加订书钉组(6.2%;95%CI 5.7-6.8%);缝线、订书钉和 2-辛基氰基丙烯酸酯组(7.1%;95%CI 6.0%-8.4%)。控制选定的基线患者、医院和手术特征的逻辑回归模型显示,与仅缝线组相比,用缝线和 2-辛基氰基丙烯酸酯封闭的患者 CABG 后 SSI 发生率显著降低(优势比 0.76;95%CI 0.68-0.85)。
观察到的 CABG 后 SSI 发生率与文献中观察到的发生率一致。缝线加 2-辛基氰基丙烯酸酯作为手术部位最后一层封闭的患者 SSI 率明显低于其他类型封闭的患者。